{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:07:09Z","timestamp":1777468029480,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Council for Science and Technology","award":["261836"],"award-info":[{"award-number":["261836"]}]},{"name":"Council for Science and Technology","award":["24335"],"award-info":[{"award-number":["24335"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejphar.2017.06.026","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:00:50Z","timestamp":1498204850000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["N -(2-morpholin-4-yl-ethyl)-2-(1naphthyloxy)acetamide inhibits the chronic constriction injury-generated hyperalgesia via the antagonism of sigma-1 receptors"],"prefix":"10.1016","volume":"812","author":[{"given":"Josu\u00e9 Vidal","family":"Espinosa-Ju\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osmar Antonio","family":"Jaramillo-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Navarrete-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"Melo-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrna","family":"D\u00e9ciga-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"L\u00f3pez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.06.026_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4155\/fmc.14.54","article-title":"Selective sigma-1 receptor antagonists for the treatment of pain","volume":"6","author":"Almansa","year":"2014","journal-title":"Futur. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.06.026_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","article-title":"Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system","volume":"97","author":"Alonso","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2017.06.026_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1744-8069-9-47","article-title":"Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury","volume":"9","author":"Bangaru","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2005.01.036","article-title":"Formalin-induced pain is reduced in \u03c31 receptor knockout mice","volume":"511","author":"Cend\u00e1n","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1254\/jphs.CR0050020","article-title":"Mechanisms of the antinociceptive action of gabapentin","volume":"100","author":"Cheng","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.06.026_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpain.2016.12.002","article-title":"Spinal D-serine increases PKC-dependent GluN1 phosphorylation contributing to the sigma-1 receptor-induced development of mechanical allodynia in a mouse model of neuropathic pain","volume":"18","author":"Choi","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.phrs.2013.05.004","article-title":"Spinal sigma-1 receptors activate NADPH oxidase 2 leading to the induction of pain hypersensitivity in mice and mechanical allodynia in neuropathic rats","volume":"74","author":"Choi","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2017.06.026_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma 1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bmc.2006.10.048","article-title":"Design, synthesis, and SAR analysis of novel selective sigma1 ligands","volume":"15","author":"Collina","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.06.026_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1054\/jpai.2000.9818","article-title":"Pain: molecular mechanisms","volume":"1","author":"Costigan","year":"2000","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2009.01.013","article-title":"Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury","volume":"92","author":"De la O-Arciniega","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2017.06.026_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib14","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1021\/jm3007323","article-title":"Synthesis and biological evaluation of the 1-arylpyrazole class of \u03c3(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)","volume":"55","author":"D\u00edaz","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.06.026_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-009-1513-8","article-title":"Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors","volume":"205","author":"Entrena","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.06.026_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pain.2009.03.011","article-title":"Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice","volume":"143","author":"Entrena","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2015.12.012","article-title":"Antinociceptive effects of a new sigma-1 receptor antagonist (N-(2-morpholin-4-yl-ethyl)-2-(1-naphthyloxy)acetamide) in two types of nociception","volume":"771","author":"Garc\u00eda-Mart\u00ednez","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib18","unstructured":"Gibaldi, M., 1991. Estimation of area under the curve. In: Philadelphia (Ed.), Biopharmaceutics and Clinical Pharmacokinetics, pp. 377\u2013378."},{"key":"10.1016\/j.ejphar.2017.06.026_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm00034a020","article-title":"Structural features important for sigma 1 receptor binding","volume":"15","author":"Glennon","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.06.026_bib20","first-page":"2","article-title":"Mecanismos del dolor neurop\u00e1tico: Del laboratorio a la cl\u00ednica","volume":"28","author":"G\u00f3mez-Barrios","year":"2009","journal-title":"Arch. Venez. Farmacol. Ter."},{"key":"10.1016\/j.ejphar.2017.06.026_bib21","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1038\/srep24591","article-title":"The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats","volume":"6","author":"Gris","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2017.06.026_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.bjp.0706764","article-title":"Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice","volume":"148","author":"Kim","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjp.2008.159","article-title":"Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice","volume":"154","author":"Kim","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib24","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.bmcl.2013.03.087","article-title":"Analysis of the molecular interactions of the potent analgesic S1RA with the \u03c31 receptor","volume":"23","author":"Laurini","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.06.026_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ddr.430320108","article-title":"Analgesic interactions produced by dipyrone and either morphine or D-propoxyphene in the pain-induced functional impairment model in rat","volume":"32","author":"L\u00f3pez-Mu\u00f1oz","year":"1994","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2017.06.026_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel o- receptor ligands \" antidystonic effects in rats suggest sigma-1 receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.06.026_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","article-title":"A method to perform direct transcutaneous intrathecal injection in rats","volume":"32","author":"Mestre","year":"1994","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2017.06.026_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1124\/mol.64.4.857","article-title":"A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission","volume":"64","author":"Mtchedlishvili","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopha.2016.02.038","article-title":"Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: a selective \u03c31 receptor ligand with antinociceptive effect","volume":"79","author":"Navarrete-V\u00e1zquez","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2017.06.026_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jpain.2012.08.006","article-title":"Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice","volume":"13","author":"Nieto","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-10-11","article-title":"Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice","volume":"10","author":"Nieto","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib33","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O\u2019Connor","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2017.06.026_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pain.2009.05.013","article-title":"Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury","volume":"145","author":"Puente","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2017.06.026_bib35","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1002\/jnr.21802","article-title":"Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway","volume":"86","author":"Roh","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2017.06.026_bib36","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization","volume":"166","author":"Romero","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejphar.2017.06.026_bib38","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1016\/j.bmc.2011.09.016","article-title":"Identification of a potent and selective \u03c3\u2081 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells","volume":"19","author":"Rossi","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.06.026_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","article-title":"Modulation of peripheral \u03bc-opioid analgesia by \u03c31 receptors","volume":"348","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.06.026_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0167-4889(01)00117-3","article-title":"Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor","volume":"1540","author":"Seth","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2017.06.026_bib41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"28","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.06.026_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4196\/kjpp.2010.14.6.359","article-title":"Sigma-1 receptor antagonist BD1047 reduces allodynia and spinal ERK phosphorylation following chronic compression of dorsal root ganglion in rats. Korean","volume":"14","author":"Son","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.06.026_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2005.06.003","article-title":"Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms","volume":"109","author":"Ueda","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.06.026_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2010\/382781","article-title":"A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain","volume":"15","author":"Watson","year":"2010","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ejphar.2017.06.026_bib45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/endo-124-3-1160","article-title":"Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary","volume":"124","author":"Wolfe","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2017.06.026_bib46","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroscience.2006.09.044","article-title":"Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit","volume":"144","author":"Xiao","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2017.06.026_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2010.06.007","article-title":"An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor","volume":"59","author":"Yoon","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.06.026_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T08:58:58Z","timestamp":1535705938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917304338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":48,"alternative-id":["S0014299917304338"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.06.026","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(2-morpholin-4-yl-ethyl)-2-(1naphthyloxy)acetamide inhibits the chronic constriction injury-generated hyperalgesia via the antagonism of sigma-1 receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}